Cargando…
Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
[Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408248/ https://www.ncbi.nlm.nih.gov/pubmed/32775891 http://dx.doi.org/10.1021/acsomega.0c02079 |
_version_ | 1783567794025005056 |
---|---|
author | Havrylyuk, Dmytro Heidary, David K. Sun, Yang Parkin, Sean Glazer, Edith C. |
author_facet | Havrylyuk, Dmytro Heidary, David K. Sun, Yang Parkin, Sean Glazer, Edith C. |
author_sort | Havrylyuk, Dmytro |
collection | PubMed |
description | [Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal center capable of forming covalent adducts with biomolecules such as DNA. Based on the strategy of exploiting structural distortion to activate photochemistry, biologically active small molecules were coordinated to a Ru(II) scaffold to create light-triggered dual-action agents. Thirteen new Ru(II) complexes with pyridyl-pyrazol(in)e ligands were synthesized, and their photochemical reactivity and anticancer properties were investigated. Isomeric bidentate ligands were investigated, where “regular” ligands (where the coordinated nitrogens in the heterocycles are linked by C–C atoms) were compared to “inverse” isomers (where the coordinated nitrogens in the heterocycles are linked by C–N atoms). Coordination of the regular 3-(pyrid-2-yl)-pyrazol(in)es to a Ru(II) bis-dimethylphenanthroline scaffold yielded photoresponsive compounds with promising photochemical and biological properties, in contrast to the inverse 1-(pyrid-2-yl)-pyrazolines. The introduction of a phenyl ring to the 1N-pyrazoline cycle increased the distortion in complexes and improved ligand release upon light irradiation (470 nm) up to 5-fold in aqueous media. Compounds 1–8, containing pyridyl-pyrazol(in)e ligands, were at least 20–80-fold more potent than the parent pyridyl-pyrazol(in)es, and exhibited biological activity in the dark, with half-maximal inhibitory concentration (IC(50)) values ranging from 0.2 to 7.6 μM in the HL60 cell line, with complete growth inhibition upon light irradiation. The diversification of coligands and introduction of a carboxylic acid into the Ru(II) complex resulted in compounds 9–12, with up to 146-fold improved phototoxicity indices compared with complexes 1–8. |
format | Online Article Text |
id | pubmed-7408248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-74082482020-08-07 Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy Havrylyuk, Dmytro Heidary, David K. Sun, Yang Parkin, Sean Glazer, Edith C. ACS Omega [Image: see text] The discovery of new light-triggered prodrugs based on ruthenium (II) complexes is a promising approach for photoactivated chemotherapy (PACT). The light-mediated activation of “strained” Ru(II) polypyridyl complexes resulted in ligand release and produced a ligand-deficient metal center capable of forming covalent adducts with biomolecules such as DNA. Based on the strategy of exploiting structural distortion to activate photochemistry, biologically active small molecules were coordinated to a Ru(II) scaffold to create light-triggered dual-action agents. Thirteen new Ru(II) complexes with pyridyl-pyrazol(in)e ligands were synthesized, and their photochemical reactivity and anticancer properties were investigated. Isomeric bidentate ligands were investigated, where “regular” ligands (where the coordinated nitrogens in the heterocycles are linked by C–C atoms) were compared to “inverse” isomers (where the coordinated nitrogens in the heterocycles are linked by C–N atoms). Coordination of the regular 3-(pyrid-2-yl)-pyrazol(in)es to a Ru(II) bis-dimethylphenanthroline scaffold yielded photoresponsive compounds with promising photochemical and biological properties, in contrast to the inverse 1-(pyrid-2-yl)-pyrazolines. The introduction of a phenyl ring to the 1N-pyrazoline cycle increased the distortion in complexes and improved ligand release upon light irradiation (470 nm) up to 5-fold in aqueous media. Compounds 1–8, containing pyridyl-pyrazol(in)e ligands, were at least 20–80-fold more potent than the parent pyridyl-pyrazol(in)es, and exhibited biological activity in the dark, with half-maximal inhibitory concentration (IC(50)) values ranging from 0.2 to 7.6 μM in the HL60 cell line, with complete growth inhibition upon light irradiation. The diversification of coligands and introduction of a carboxylic acid into the Ru(II) complex resulted in compounds 9–12, with up to 146-fold improved phototoxicity indices compared with complexes 1–8. American Chemical Society 2020-07-23 /pmc/articles/PMC7408248/ /pubmed/32775891 http://dx.doi.org/10.1021/acsomega.0c02079 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Havrylyuk, Dmytro Heidary, David K. Sun, Yang Parkin, Sean Glazer, Edith C. Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title | Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based
Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title_full | Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based
Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title_fullStr | Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based
Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title_full_unstemmed | Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based
Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title_short | Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based
Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy |
title_sort | photochemical and photobiological properties of pyridyl-pyrazol(in)e-based
ruthenium(ii) complexes with sub-micromolar cytotoxicity for phototherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408248/ https://www.ncbi.nlm.nih.gov/pubmed/32775891 http://dx.doi.org/10.1021/acsomega.0c02079 |
work_keys_str_mv | AT havrylyukdmytro photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy AT heidarydavidk photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy AT sunyang photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy AT parkinsean photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy AT glazeredithc photochemicalandphotobiologicalpropertiesofpyridylpyrazolinebasedrutheniumiicomplexeswithsubmicromolarcytotoxicityforphototherapy |